14-day RSI
63.98
+8.56+15.45%
27 November 2024
Summary:
NovoCure Limited stock 14-day relative strength index is 63.98, with the most recent change of +8.56 (+15.45%) on 27 November 2024. According to this value, NVCR stock is neither oversold nor overboughtNVCR RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +15.4% | +8.6% | +0.3% | +0.1% |
| 1 m1 month | +21.2% | +18.9% | -1.7% | +2.0% |
| 3 m3 months | +39.0% | +8.2% | -10.8% | +6.9% |
| 6 m6 months | -11.1% | -15.9% | +7.4% | +7.3% |
| ytdytd | +3.4% | +30.0% | +27.2% | -52.4% |
| 1 y1 year | +58.8% | +62.5% | +16.1% | -60.5% |
| 5 y5 years | -8.6% | -78.9% | -78.8% | -73.9% |
NVCR RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 63.98 | at high | 40.38 | +58.4% |
| 3 m | 3 months | 63.98 | at high | 32.63 | +96.1% |
| 6 m | 6 months | 75.97 | -15.8% | 28.42 | +125.1% |
| 1 y | 1 year | 87.64 | -27.0% | 28.42 | +125.1% |
| 3 y | 3 years | 87.64 | -27.0% | 14.26 | +348.7% |
| 5 y | 5 years | 89.30 | -28.4% | 14.26 | +348.7% |
| alltime | all time | 89.30 | -28.4% | 0.00 | -100.0% |
NovoCure Limited Stock RSI History
| Date | Value |
|---|---|
| 2024 | 63.98(+3.4%) |
| 2023 | 61.89(+29.7%) |
| 2022 | 47.71(+42.0%) |
| 2021 | 33.60(-49.9%) |
| 2020 | 67.08(+37.0%) |
| Date | Value |
|---|---|
| 2019 | 48.97(-4.0%) |
| 2018 | 50.99(-5.9%) |
| 2017 | 54.20(+28.2%) |
| 2016 | 42.27(+24.6%) |
| 2015 | 33.92 |
FAQ
- What is NovoCure Limited 14-day relative strength index?
- What is the all time high 14-day RSI for NovoCure Limited?
What is NovoCure Limited 14-day relative strength index?
The current 14-day RSI of NVCR is 63.98
What is the all time high 14-day RSI for NovoCure Limited?
NovoCure Limited all-time high 14-day relative strength index is 89.30